Form 4: OPKO Health CEO Phillip Frost Acquires 200,000 Shares

OPKO Health's CEO, Phillip Frost, purchased 200,000 shares of common stock at an average price of $1.7391 on March 17, 2025.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, Inc., acquired 200,000 shares of common stock on March 17, 2025.
• The shares were purchased at a weighted average price of $1.7391, with individual transactions ranging from $1.73 to $1.745.
• Following the transaction, Dr. Frost directly owns 3,568,951 shares and indirectly owns 213,501,448 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
• Frost Gamma Investments Trust is a 10% owner of OPKO Health.
• Dr. Frost disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase is a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• The CEO's purchase of shares may signal confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.

Stakeholder Impact

• The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates